This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Invendo Medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors

NEW YORK and KISSING, Germany, July 30, 2014 /PRNewswire/ -- invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robotic") colonoscopy system, today announced the appointment of Nachum (Homi) Shamir, a worldwide recognized medical device executive, as a new member of its supervisory board.

invendo medical LOGO.

Mr. Shamir is a highly respected global visionary in the medical device industry. In his most recent assignment he served as President and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: GIVN), the pioneer in capsule endoscopy technology which  revolutionized the way gastroenterologists diagnose and monitor diseases of the GI tract through the development and marketing of a game-changing diagnostic tool in the form of small capsule cameras (PillCam). Given Imaging was acquired by Covidien plc (NYSE: COV) in February 2014 in a transaction valued at approximately $1 billion. Under Mr. Shamir's tenure Given Imaging has grown revenues from $ 85 million annually to close to $200 million and achieved significant profitability based on diversified GI product portfolios and a globalized commercial footprint.

Mr. Shamir replaces Mr. Sidney Braginsky, former President of Olympus America Inc., who retired from the board. Furthermore Stefan Fischer, General Partner and CFO of TVM Capital replaced Dr. Axel Polack.

Timo Hercegfi, CEO of invendo medical, commented, "Following our first system installations in the U.S. invendo is at an exciting time of its company life. We are planning to have a significant impact on colon cancer screening in the US with our computer assisted invendoscope as well as additional single-use endoscopes to be added to the invendo product portfolio. In light of recent public discussions about the outbreak of an antibiotic-resistant superbug in Illinois, which was traced to contaminated GI endoscopes - although reprocessing standard operating procedures had been adhered to -  we are certainly at the right place at the right time with our single-use colonoscopy solution. Homi Shamir is a highly professional individual with an outstanding track record of generating commercial success. I am convinced that he will give us a major boost in creating value for our customers, patients opting for invendoscopy, payers and last but not least our shareholders ."

Given Imaging was the second successful exit for Mr. Shamir who previously sold Scitex Digital Printing Ltd. in 2004 to Eastman Kodak for $ 262 million. Prior to joining Given Imaging Ltd. Mr. Shamir served as Corporate Vice President of the Eastman Kodak Company and as the President of Eastman Kodak's Transaction and Industrial Solutions Group. From June 2003 to January 2004, Mr. Shamir served as the President and Chief Executive Officer of Scitex Corporation, a NASDAQ listed company, following service in various roles in Scitex and its affiliates from 1993. Before joining Scitex Mr. Shamir held senior management positions at various international high tech companies mainly in the Asia Pacific region. Mr. Shamir holds a B.Sc from the Hebrew University of Jerusalem and an M.P.A. from Harvard University.  

About the invendoscopy ™ system

The invendoscope™ SC20 has several features that are new to the field of colonoscopy:

  • it is a single-use colonoscope with a working channel
  • it is not pushed or pulled, but uses a computer-assisted ("robotic") gentle drive technology
  • all endoscopic functions are performed using a handheld device and
  • it reduces forces on the colon wall

invendo medical is also developing further single-use GI endoscopes based on its unique technology platform.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs